172 related articles for article (PubMed ID: 19094976)
1. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
Gunawardana CG; Memari N; Diamandis EP
Clin Biochem; 2009 Mar; 42(4-5):426-9. PubMed ID: 19094976
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
Kalniņa Z; Siliņa K; Meistere I; Zayakin P; Rivosh A; Abols A; Leja M; Minenkova O; Schadendorf D; Linē A
J Immunol Methods; 2008 May; 334(1-2):37-50. PubMed ID: 18314130
[TBL] [Abstract][Full Text] [Related]
3. Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays.
Ramirez AB; Lampe PD
Cancer Biomark; 2010-2011; 8(4-5):293-307. PubMed ID: 22045360
[TBL] [Abstract][Full Text] [Related]
4. The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.
Ehrlich JR; Tang L; Caiazzo RJ; Cramer DW; Ng SK; Ng SW; Liu BC
Methods Mol Biol; 2008; 441():175-92. PubMed ID: 18370319
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody signatures: a promising new test for prostate cancer.
Harv Mens Health Watch; 2007 May; 11(10):7. PubMed ID: 17514825
[No Abstract] [Full Text] [Related]
6. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
Carlsson A; Wingren C; Ingvarsson J; Ellmark P; Baldertorp B; Fernö M; Olsson H; Borrebaeck CA
Eur J Cancer; 2008 Feb; 44(3):472-80. PubMed ID: 18171612
[TBL] [Abstract][Full Text] [Related]
7. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid.
Roche S; Dauvilliers Y; Tiers L; Couderc C; Piva MT; Provansal M; Gabelle A; Lehmann S
J Immunol Methods; 2008 Sep; 338(1-2):75-8. PubMed ID: 18656479
[TBL] [Abstract][Full Text] [Related]
9. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.
Miller JC; Zhou H; Kwekel J; Cavallo R; Burke J; Butler EB; Teh BS; Haab BB
Proteomics; 2003 Jan; 3(1):56-63. PubMed ID: 12548634
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
[TBL] [Abstract][Full Text] [Related]
11. Identifying autoantibody signatures in cancer: a promising challenge.
Desmetz C; Maudelonde T; Mangé A; Solassol J
Expert Rev Proteomics; 2009 Aug; 6(4):377-86. PubMed ID: 19681673
[TBL] [Abstract][Full Text] [Related]
12. Development of miniaturized immunoassay: influence of surface chemistry and comparison with enzyme-linked immunosorbent assay and Western blot.
El Khoury G; Laurenceau E; Chevolot Y; Mérieux Y; Desbos A; Fabien N; Rigal D; Souteyrand E; Cloarec JP
Anal Biochem; 2010 May; 400(1):10-8. PubMed ID: 20079705
[TBL] [Abstract][Full Text] [Related]
13. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
[TBL] [Abstract][Full Text] [Related]
14. [Purification and characterization of corresponding antigen recognized by monoclonal antibody 183B2 against ovarian carcinoma].
Guo HF; Feng J; Zhang H; Yao Y; Cheng HY
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):614-8. PubMed ID: 16202318
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody biomarkers for the detection of serous ovarian cancer.
Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
[TBL] [Abstract][Full Text] [Related]
16. Seromic profiling of ovarian and pancreatic cancer.
Gnjatic S; Ritter E; Büchler MW; Giese NA; Brors B; Frei C; Murray A; Halama N; Zörnig I; Chen YT; Andrews C; Ritter G; Old LJ; Odunsi K; Jäger D
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5088-93. PubMed ID: 20194765
[TBL] [Abstract][Full Text] [Related]
17. Biomolecular interaction monitoring of autoantibodies by scanning surface plasmon resonance microarray imaging.
Lokate AM; Beusink JB; Besselink GA; Pruijn GJ; Schasfoort RB
J Am Chem Soc; 2007 Nov; 129(45):14013-8. PubMed ID: 17941638
[TBL] [Abstract][Full Text] [Related]
18. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
19. Development of a cluster of differentiation antibody-based protein microarray.
Abdo M; Irving B; Hudson P; Zola H
J Immunol Methods; 2005 Oct; 305(1):3-9. PubMed ID: 16139293
[TBL] [Abstract][Full Text] [Related]
20. Autoreactive antibodies raised by self derived de novo peptides can identify unrelated antigens on protein microarrays. Are autoantibodies really autoantibodies?
Kroening K; Johnston SA; Legutki JB
Exp Mol Pathol; 2012 Jun; 92(3):304-11. PubMed ID: 22421442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
